Source: Washington Examiner Author: David Hogberg

A new study finds that COVID-19 patients with acute respiratory infections may improve with a regimen of Vitamin D3, hydroxychloroquine, and azithromycin.

The study was published in the Journal of Steroid Biochemistry and Molecular Biology and employed a randomized controlled trial, considered the gold standard in medical research, on patients who had COVID-19-related pneumonia in a hospital in Spain. All patients were given hydroxychloroquine and azithromycin, and one group was given Vitamin D3 (calcifediol) while the other group was not. Hydroxychloroquine is an “ionophore” that can transport particular molecules across a cell membrane, while azithromycin is an antibiotic used to treat lung infections.

Of the 50 patients treated with Vitamin D3, only two were admitted to an intensive care unit. Of the 26 patients who did not receive Vitamin D3, 13 were admitted to the ICU, and two died.

One limit to the study was its small size of only 76 patients. It also doesn’t resolve the question of whether Vitamin D3 would work without hydroxychloroquine.




Related: Spanish Study -The Prognostic Value of Eosinophil Recovery in COVID-19: A Multicentre, Retrospective Cohort Study on Patients Hospitalised in Spanish Hospitals.

Open letter to authors of COVID-19 trials, medical journals and scientific community

Brazil: Early treatment with Covid Kit including HCQ is effective and safe, says MS doctor

Study: Strategy – HCQ + AZ treats mild COVID-19 to reduce hospital admissions and complications.

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »